Novobiocin:
Supplementary Figure 1:
Evaluation of optimal hydrogel functionality. Hydrogels (10 µl) were synthesized by mixing different molar ratios of GyrB-Cys and Cys-GyrB-Cys (total amount of 40 nmol (1 mg)) with 20 nmol (22.2 µg) coumermycin and 5 nmol (178.6 µg) PEG-VS in reaction buffer and incubated for 24 h at 25°C for hydrogel formation. Hydrogels were then incubated in synthetic body fluid (SBF) for 24 h, further transferred to SBF and dissolution was determined in the presence or absence of 100 µM novobiocin by quantifying released protein-PEG conjugates. Error bars represent the standard deviation of 5 replicas.
Figure S2 . The protein and PEG-VS control mix was prepared by omitting PEG-VS or the proteins respectively. Coumermycin was omitted in all mixes in order to avoid gel formation. All samples were incubated for 24 h at 25°C followed by lyophilization and dissolution in D 2 O. 1 H-NMR (300 MHz) spectra were recorded using a Bruker Spectrometer ARX 300. Chemical shifts were calibrated on the solvent peak. Representative peaks of the reactive vinylsulfone group of the polymer are marked with a dotted line: 1) 6.87 ppm (2d, 2H, =CH2) and 2) 6.36 ppm (dd, 1H, -SO2CH=). The peaks of the vinylsulfone group disappear in the hydrogel mix thereby confirming the quantitative reaction of the PEG-VS with the protein. 
